Cargando…
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study
INTRODUCTION: Remdesivir is a registered treatment for hospitalised patients with COVID-19 that has moderate clinical effectiveness. Anecdotally, some patients’ respiratory insufficiency seemed to recover particularly rapidly after initiation of remdesivir. In this study, we investigated if this rap...
Autores principales: | Leegwater, Emiel, Dol, Lisa, Benard, Menno R., Roelofsen, Eveline E., Delfos, Nathalie M., van der Feltz, Machteld, Mollema, Femke P. N., Bosma, Liesbeth B. E., Visser, Loes E., Ottens, Thomas H., van Burgel, Nathalie D., Arbous, Sesmu M., El Bouazzaoui, Lahssan H., Knevel, Rachel, Groenwold, Rolf H. H., de Boer, Mark G. J., Visser, Leo G., Rosendaal, Frits R., Wilms, Erik B., van Nieuwkoop, Cees |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600071/ https://www.ncbi.nlm.nih.gov/pubmed/37801280 http://dx.doi.org/10.1007/s40121-023-00874-2 |
Ejemplares similares
-
Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients
por: Leegwater, E., et al.
Publicado: (2022) -
Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists
por: Meynaar, Iwan A., et al.
Publicado: (2022) -
De SARS-CoV-2-antigeentest is niet accuraat genoeg
por: Smits, Febe, et al.
Publicado: (2021) -
The impact of an infectious disease expert team on outpatient parenteral antimicrobial treatment in the Netherlands
por: Wijnakker, Roos, et al.
Publicado: (2018) -
Measles outbreaks – potential threat for health care professionals
por: Westgeest, A.C., et al.
Publicado: (2020)